I am Elena Olmastroni, a post doc researcher at the Department of Pharmacological and Biomolecular Sciences of the University of Milan (Italy). I completed a master degree in Biostatistics at the University of Milan-Bicocca (Italy) in 2017, with a thesis on “Nested case-control studies to assess the association between pioglitazone use and bladder cancer risk in a Swedish cohort with type 2 diabetes”, a project conducted in collaboration with the Centre for Pharmacoepidemiology of the Karolinska Institutet (Sweden). Then, I got a PhD in Experimental, Clinical and Biomolecular Pharmacological Science in April 2022. During my PhD programme, I have gain experiences and improved skills related to: •integrate and use the pharmacological knowledge acquired in order to developing interdisciplinary pharmacoepidemiological studies in the field of health science; •design, conduction and analysis of pharmacoepidemiology and pharmacoutilization studies, mainly through healthcare utilization databases; •the evaluation of the risk/benefit profile of drugs in the context of real-world clinical practice, through both the use of administrative databases and the application of meta-analytic methodologies based on the published results of clinical and/or experimental studies.